Er:YAG ablative fractional laser-assisted methyl aminolevulinate photodynamic therapy (AFL-PDT) has shown significantly higher efficacy and a lower recurrence rate at 12 months than methyl aminolevulinate photodynamic therapy (MAL-PDT) for treatment of Bowen's disease (BD). However, long-term follow up data are not available.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Difference of short-term complete response (CR) rate between AFL-PDT and MAL-PDT
Timeframe: Short-term CR rate was evaluated at 3 months
Difference of long-term complete response (CR) rate between AFL-PDT and MAL-PDT
Timeframe: Long-term CR rate was evaluated at 60 months
Difference of long-term recurrence rate between AFL-PDT and MAL-PDT at 60 months
Timeframe: Recurrent rate was evaluated at 60 months